Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer

Breast Cancer Research and Treatment

Volumn 48, Issue 2, 1998, Pages 125-133

  Roka, Sebastian ^a   Fiegl, Michael ^a   Zojer, Niklas ^a   Filipits, Martin ^a   Schuster, Rudolf ^a   Steiner, Birgit ^a   Jakesz, Raimund ^a   Huber, Heinz ^a   Drach, Johannes ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aneuploidy; Breast cancer; FISH; Interphase cytogenetics; Metastasis

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CELL POPULATION; CENTROMERE; CHROMOSOME 8; CYTOGENETICS; CYTOLOGY; DIPLOIDY; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; INTERPHASE; MAJOR CLINICAL STUDY; METASTASIS; PLOIDY; PRIORITY JOURNAL; TETRASOMY; TRISOMY;

EID: 0031979655     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005937305102     Document Type: Article

References (25)

1. Le Beau MM: Detecting genetic changes in human tumor cells: have scientists 'gone fishing'? Blood 81: 1979-1983, 1993
2. Devilee P, Cornelisse CJ: Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198: 113-130, 1994
3. Pandis N, Heim S, Bardi G, Limon J, Mandahl N, Mitelman F: Improved technique for short-term culture and cytogenetic analysis of human breast cancer. Genes Chrom Cancer 5: 14-20, 1992
4. Fiegl M, Tueni C, Schenk T, Jakesz R, Gnant M, Reiner A, Rudas M, Pirc-Danoewinata H, Marosi C, Huber H, Drach J: Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumor heterogeneity in breast cancer. Br J Cancer 72: 51-55, 1995
5. Zojer N, Fiegl M, Angerler J, Müllauer L, Gsur A, Roka S, Pecherstorfer M, Huber H, Drach J: Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients. Br J Cancer 75: 403-407, 1997
6. Bieche I, Lidereau R: Genetic alterations in breast cancer. Genes Chrom Cancer 14: 227-251, 1995
7. Afify A, Bland KI, Mark HFL: Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer: Breast Cancer Res Treat 38: 201-208, 1996
8. Simpson JF, Quan DE, Ho JP, Slovak ML: Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization. Am J Pathol 149: 751-758, 1996
9. Rohen C, Meyer-Bolte K, Bonk U, Ebel T, Staats B, Leuschner E, Gohla G, Caselitz J, Bartnitzke S, Bullerdiek J: Trisomy 8 and 18 as frequent clonal and single-cell aberrations in 185 primary breast carcinomas. Cancer Genet Cytogenet 80: 33-39, 1995
10. Pinkel D, Straume T, Gray JW: Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83: 2934-2938, 1986
11. Drach J, Angerler J, Schuster J, Rothermundt CA, Thalhammer R, Haas OA, Jäger U, Fiegl M, Geissler K, Ludwig H, Huber H: Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 86: 3915-3921, 1995
12. Hopman AHN, Ramaekers FCS, Raap AK, Beck JLM, Devilee P, van der Ploeg M, Vooijs GP: In situ hybridization as a tool to study numerical aberrations in solid bladder tumors. Histochemistry 89: 307-316, 1988
13. Eastmond DA, Schuler M, Rupa DS: Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutation Res 348: 153-162, 1995
14. Herrington CS, Cooper K, McGee JO'D: Interphase cytogenetics: analysis of numerical chromosome aberrations in isolated cells. J Pathol 175: 283-295, 1995
15. Murphy DS, Hoare SF, Going JJ, Mallon EEA, George WD, Kaye SB, Brown R, Black DM, Keith WN: Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst 87: 1694-1704, 1995
16. Micale MA, Visscher DW, Gulino SE, Wolman SR: Chromosomal aneuploidy in proliferative breast disease. Hum Pathol 25: 29-35, 1994
17. Arnoldus EPJ, Dreef EJ, Nordermeer IA, Verheggen MM, Thierry RF, Peters ACB, Cornelisse CJ, van der Ploeg M, Raap AK: Feasibility of in situ hybridization with chromosome specific DNA probes on paraffin wax embedded tissue. J Clin Pathol 44: 900-904, 1991
18. Qian J, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Lieber MM, Jenkins RB: Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol 149: 1193-1199, 1996
19. Kibbelaar RE, Kok F, Dreef EJ, Kleiverda JK, Cornelisse CJ, Raap AK, Kluin PM: Statistical methods in interphase cytogenetics: an experimental approach. Cytometry 14:716-724, 1993
20. Dutrillaux B, Gerbault-Sereau M, Remvikos Y, Zafrani B, Prieur M: Breast cancer genetic evolution. 1. Data from cytogenetics and DNA content. Breast Cancer Res Treat 19: 245-255, 1991
21. Shay JW, Wright WE, Werbin H: Toward a molecular understanding of human breast cancer: a hypothesis. Breast Cancer Res Treat 25: 83-94, 1993
22. Biesterfeld S, Gerres K, Fischer-Wein G, Böcking A: Polyploidy in non-neoplastic tissue. J Clin Pathol 47: 38-42, 1994
23. Müller P, Weckermann D, Riethmüller G, Schlimok G: Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. Cancer Genet Cytogenet 88: 8-16, 1996
24. Chen Z, Wang DD, Peier A, Stone JF, Sandberg AA: FISH in the evaluation of pleural and ascitic fluid. Cancer Genet Cytogenet 84: 116-119, 1995
25. Ichikawa D, Hashimoto N, Hoshima M, Yamaguchi T, Sawai K, Nakamura Y, Takahashi T, Abe T, Inazawa J: Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer 77: 2064-2069, 1996